by RSNA
A podcast from the Radiology: Imaging Cancer journal focusing on recently publications and trending topics. Journal editor-in-chief: Dr. Gary Luker Host: Jana Ivanidze, MD, PhD Production: Kelly Myers
Language
🇺🇲
Publishing Since
5/27/2020
Email Addresses
1 available
Phone Numbers
0 available
March 7, 2025
<p>Dr. Brandon K.K. Fields speaks with Dr. Jennifer Holter-Chakrabarty about her groundbreaking research on fluorine-18 fluorothymidine (FLT) PET in the imaging of gastrointestinal graft-versus-host disease (GVHD) after allogeneic stem cell transplantation. Together, they explore a potential future role for FLT-PET in detection of early and/or subclinical GVHD, which may serve to guide future treatment strategies for transplant patients in years to come.</p> <p><a href= "https://doi.org/10.1148/rycan.240096"><sup>18</sup>F-FLT PET and Blood-based Biomarkers for IdentifyingGastrointestinal Graft versus Host Disease after Allogeneic CellTransplantation. Holter-Chakrabarty and McNally et al. Radiology: Imaging Cancer 2025; 7(1):e240096. </a></p>
October 30, 2024
<p class="MsoNormal">Dr. Lauren Burkard-Mandel discusses the importance of breast cancer screening at age 40 with guest Dr. Debra Monticciolo. They explore the 2023 U.S. Preventive Services Task Force's draft statement advocating for the initiation of biennial mammograms at age 40, down from the previous age of 50. Tune in for an insightful discussion that could impact women's health decisions for years to come!</p> <p style="background: white;"><span style= "font-size: 9.5pt; font-family: 'Open Sans',sans-serif; color: #22242f;"> Articles discussed:<br /> <a href="https://doi.org/10.1093/jbi/wbad103"><span style= "color: #22242f;">https://doi.org/10.1093/jbi/wbad103</span></a><br /> <a title= "Original URL: https://doi.org/10.1002/cncr.33846 Click to follow link." href= "https://nam02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fdoi.org%2F10.1002%2Fcncr.33846&data=05%7C02%7Ckmyers%40rsna.org%7Cf288866c543a40dab30c08dcf5f5cd0e%7Cfb5fefcd7ca642f3b443917c2a68cecd%7C0%7C0%7C638655683279098936%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=jaTXI4uHQvAj6DF50Gs0aHO9ZqrmNG4kxOK1pUSFb7g%3D&reserved=0"> <span style= "color: #22242f;">https://doi.org/10.1002/cncr.33846</span></a></span></p>
September 5, 2024
<p>Dr. Daniel Kwon interviews Dr. Peter Choyke, a leading expert in molecular imaging and nuclear medicine, about the recent advancements in the use of PSMA PET imaging for prostate cancer. </p> <p>Check out more articles on this topic<br /> <a title= "https://pubs.rsna.org/page/imaging-cancer/prostate-collection" href= "https://pubs.rsna.org/page/imaging-cancer/prostate-collection" data-ogsc="">Prostate Cancer Special Collection</a></p>
Radiological Society of North America (RSNA)
Radiological Society of North America (RSNA)
The Radiological Society of North America
AJR
Andrew Dixon & Frank Gaillard
The New York Times
Freakonomics Radio + Stitcher
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.